X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES IPCA LABS SUVEN LIFESCIENCES/
IPCA LABS
 
P/E (TTM) x 18.9 25.8 73.2% View Chart
P/BV x 3.7 4.4 84.6% View Chart
Dividend Yield % 0.6 0.1 575.0%  

Financials

 SUVEN LIFESCIENCES   IPCA LABS
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
IPCA LABS
Mar-18
SUVEN LIFESCIENCES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs251695 36.1%   
Low Rs155400 38.8%   
Sales per share (Unadj.) Rs49.1260.2 18.9%  
Earnings per share (Unadj.) Rs9.719.0 51.2%  
Cash flow per share (Unadj.) Rs11.433.1 34.5%  
Dividends per share (Unadj.) Rs1.501.00 150.0%  
Dividend yield (eoy) %0.70.2 404.9%  
Book value per share (Unadj.) Rs60.3213.0 28.3%  
Shares outstanding (eoy) m127.28126.20 100.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.1 196.2%   
Avg P/E ratio x20.928.9 72.3%  
P/CF ratio (eoy) x17.816.6 107.5%  
Price / Book Value ratio x3.42.6 130.9%  
Dividend payout %15.45.3 292.8%   
Avg Mkt Cap Rs m25,82569,120 37.4%   
No. of employees `0001.113.3 8.1%   
Total wages/salary Rs m6137,359 8.3%   
Avg. sales/employee Rs Th5,832.62,477.4 235.4%   
Avg. wages/employee Rs Th571.5555.2 102.9%   
Avg. net profit/employee Rs Th1,153.8180.6 638.7%   
INCOME DATA
Net Sales Rs m6,25332,836 19.0%  
Other income Rs m233418 55.7%   
Total revenues Rs m6,48533,254 19.5%   
Gross profit Rs m1,9824,505 44.0%  
Depreciation Rs m2131,777 12.0%   
Interest Rs m46240 19.3%   
Profit before tax Rs m1,9552,905 67.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718511 140.5%   
Profit after tax Rs m1,2372,394 51.7%  
Gross profit margin %31.713.7 231.0%  
Effective tax rate %36.717.6 208.8%   
Net profit margin %19.87.3 271.3%  
BALANCE SHEET DATA
Current assets Rs m5,62219,455 28.9%   
Current liabilities Rs m1,16810,076 11.6%   
Net working cap to sales %71.228.6 249.4%  
Current ratio x4.81.9 249.4%  
Inventory Days Days8198 83.2%  
Debtors Days Days3667 53.7%  
Net fixed assets Rs m3,32520,260 16.4%   
Share capital Rs m127252 50.4%   
"Free" reserves Rs m7,54726,633 28.3%   
Net worth Rs m7,67426,886 28.5%   
Long term debt Rs m142,340 0.6%   
Total assets Rs m9,13541,173 22.2%  
Interest coverage x43.213.1 330.1%   
Debt to equity ratio x00.1 2.1%  
Sales to assets ratio x0.70.8 85.8%   
Return on assets %14.06.4 219.5%  
Return on equity %16.18.9 181.0%  
Return on capital %26.010.8 241.9%  
Exports to sales %047.6 0.0%   
Imports to sales %014.9 0.0%   
Exports (fob) Rs mNA15,642 0.0%   
Imports (cif) Rs mNA4,884 0.0%   
Fx inflow Rs m5,06615,642 32.4%   
Fx outflow Rs m2,0014,884 41.0%   
Net fx Rs m3,06510,759 28.5%   
CASH FLOW
From Operations Rs m6993,411 20.5%  
From Investments Rs m-6-1,354 0.5%  
From Financial Activity Rs m-577-1,304 44.2%  
Net Cashflow Rs m116753 15.4%  

Share Holding

Indian Promoters % 63.4 45.9 138.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.4 -  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.4 209.8%  
Shareholders   37,287 36,892 101.1%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY19); Net Profit Up 113.4% (Quarterly Result Update)

Jun 3, 2019 | Updated on Jun 3, 2019

For the quarter ended March 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 113.4% YoY). Sales on the other hand came in at Rs 8 bn (up 6.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jul 19, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - PANACEA BIOTECH COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS